PMC:7291971 / 17844-18064 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T401","span":{"begin":68,"end":70},"obj":"GO:0006272"},{"id":"T402","span":{"begin":112,"end":117},"obj":"NCBITaxon:10239"},{"id":"T403","span":{"begin":139,"end":147},"obj":"SP_10"},{"id":"T404","span":{"begin":155,"end":160},"obj":"PR:000000125"},{"id":"T405","span":{"begin":161,"end":168},"obj":"GO:0032991"},{"id":"T406","span":{"begin":196,"end":204},"obj":"NCBITaxon:7742"},{"id":"T407","span":{"begin":212,"end":219},"obj":"NCBITaxon:10239"},{"id":"T38","span":{"begin":66,"end":67},"obj":"GO:0006272"},{"id":"T39","span":{"begin":68,"end":69},"obj":"GO:0006272"}],"text":"Compounds 1–16 designed as mimics of the transition state of RNA 2′-O-methylation were screened against several viral RNA 2′-O-MTases from SARS-CoV (nsp10/nsp16 complex), Zika, West-Nile, Dengue, Vaccinia (VP39) viruses."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T64","span":{"begin":61,"end":64},"obj":"Body_part"},{"id":"T65","span":{"begin":118,"end":121},"obj":"Body_part"}],"attributes":[{"id":"A64","pred":"fma_id","subj":"T64","obj":"http://purl.org/sig/ont/fma/fma67095"},{"id":"A65","pred":"fma_id","subj":"T65","obj":"http://purl.org/sig/ont/fma/fma67095"}],"text":"Compounds 1–16 designed as mimics of the transition state of RNA 2′-O-methylation were screened against several viral RNA 2′-O-MTases from SARS-CoV (nsp10/nsp16 complex), Zika, West-Nile, Dengue, Vaccinia (VP39) viruses."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T37","span":{"begin":139,"end":147},"obj":"Disease"},{"id":"T38","span":{"begin":171,"end":175},"obj":"Disease"},{"id":"T39","span":{"begin":188,"end":194},"obj":"Disease"},{"id":"T40","span":{"begin":196,"end":204},"obj":"Disease"}],"attributes":[{"id":"A37","pred":"mondo_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A38","pred":"mondo_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/MONDO_0018661"},{"id":"A39","pred":"mondo_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/MONDO_0005502"},{"id":"A40","pred":"mondo_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/MONDO_0002595"}],"text":"Compounds 1–16 designed as mimics of the transition state of RNA 2′-O-methylation were screened against several viral RNA 2′-O-MTases from SARS-CoV (nsp10/nsp16 complex), Zika, West-Nile, Dengue, Vaccinia (VP39) viruses."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T148","span":{"begin":10,"end":14},"obj":"http://purl.obolibrary.org/obo/CLO_0001046"},{"id":"T149","span":{"begin":212,"end":219},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"Compounds 1–16 designed as mimics of the transition state of RNA 2′-O-methylation were screened against several viral RNA 2′-O-MTases from SARS-CoV (nsp10/nsp16 complex), Zika, West-Nile, Dengue, Vaccinia (VP39) viruses."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T36","span":{"begin":70,"end":81},"obj":"http://purl.obolibrary.org/obo/GO_0032259"}],"text":"Compounds 1–16 designed as mimics of the transition state of RNA 2′-O-methylation were screened against several viral RNA 2′-O-MTases from SARS-CoV (nsp10/nsp16 complex), Zika, West-Nile, Dengue, Vaccinia (VP39) viruses."}

{"project":"LitCovid-sentences","denotations":[{"id":"T111","span":{"begin":0,"end":220},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Compounds 1–16 designed as mimics of the transition state of RNA 2′-O-methylation were screened against several viral RNA 2′-O-MTases from SARS-CoV (nsp10/nsp16 complex), Zika, West-Nile, Dengue, Vaccinia (VP39) viruses."}